• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Nycomed shoots down Pharmacia rumors

Article

Contrast agent developer Hafslund Nycomed issued a strong denialof rumors circulating last month that Swedish firm Pharmacia wouldmake a bid to buy the Oslo, Norway, company. The rumors originatedin the Oslo stock market, according to Reuters. Nycomed

Contrast agent developer Hafslund Nycomed issued a strong denialof rumors circulating last month that Swedish firm Pharmacia wouldmake a bid to buy the Oslo, Norway, company. The rumors originatedin the Oslo stock market, according to Reuters.

Nycomed and Pharmacia have had no contacts regarding such a buyout,said Eric Cameron, senior vice president of corporate communicationsfor Nycomed.

"The rumor on negotiations or contacts or a declared willor wish from Pharmacia to buy shares or form an alliance withHafslund Nycomed is rumor and contains no reality," Camerontold SCAN. "There has been no contact between the parties."

Cameron said Nycomed did not know the source of the rumor,but said it may have been fueled in part by Nycomed's stated desireto form alliances with other companies in various fields.

"If we can identify possible partners, possible ways ofconducting our business better, we are open for such discussion,"Cameron said. "It doesn't necessarily mean we are sellingourselves. This might have misled people."

Related Videos
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.